Clinical Trial Update: To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety, tolerability, and pharmacokinetics of AZD5634 via inhaled and IV administration in cystic fibrosis patients; completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• AZD5634

Snippet

Sponsor: AstraZeneca | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2018-11-05